Patents by Inventor ROBERT MINO

ROBERT MINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF NITROUS OXIDE AND 5-HT2A RECEPTOR AGONISTS
    Publication number: 20260240901
    Abstract: Combination drug therapies comprising a 5-HT2A receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, xenon, argon, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric disease using the combination drug therapy, for example, via aerosol inhalation.
    Type: Application
    Filed: March 29, 2023
    Publication date: August 20, 2026
    Applicant: Cybin IRL Limited
    Inventors: Michael Palfreyman, Alex Nivorozhkin, Brett J. Greene, Robert Mino, Amy Claire Reichelt, Geoffrey B. Varty
  • METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS
    Publication number: 20250205198
    Abstract: Provided are methods for delivering psychedelic drugs such as tryptamine psychedelics to a patient in need thereof via inhalation. The psychedelic drug is delivered in the form of an aerosol, such as a mist or a dry powder. Methods for treating a central nervous system (CNS) disorder or psychological disorder via inhalation routes are provided.
    Type: Application
    Filed: March 28, 2023
    Publication date: June 26, 2025
    Applicant: Cybin IRL Limited
    Inventors: Michael Palfreyman, Alex Nivorozhkin, Brett J. Greene, Robert Mino
  • COMBINATION DRUG THERAPIES
    Publication number: 20240366655
    Abstract: Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric disease using the combination drug therapy, for example, via aerosol inhalation.
    Type: Application
    Filed: March 31, 2022
    Publication date: November 7, 2024
    Applicant: CYBIN IRL LIMITED
    Inventors: MICHAEL PALFREYMAN, ALEX NIVOROZHKIN, BRETT J. GREENE, ROBERT MINO